Skip to main content

Table 4 Prognosis of 76 patients with HCC

From: Clinical features of hepatocellular carcinoma with hepatitis B virus among patients on Nucleos(t) ide analog therapy

 

Anti-viral group

n = 33(%)

Non anti-viral group

n = 43(%)

P value

Prognosis

 Survival

30(90.91%)

14(32.54%)

< 0.05

 Death

3(9.09%)

29(67.46%)

 
Back to article page

Infectious Agents and Cancer

ISSN: 1750-9378

Contact us